MATCH biosystems, founded in June 2020 in Valencia, develops rapid, non-invasive, low-cost diagnostic tests with high sensitivity and specificity to detect pathogens in clinical hospital and veterinary environments. The company has focused its first launch on detecting several high-prevalence pathogens in intensive care units (ICU). It aims to deliver results in minutes, versus the 24–72 hours required by current devices. MATCH is led by Ramón Martínez Mañez, director of the Institute of Molecular Recognition Research and Technological Development (IDM) at the Polytechnic University of Valencia. The financing received from Clave (via Tech Transfer UPV) and BHV Partners will be used to validate a proof of concept, obtain a minimum viable product (MVP) and begin regulatory approval processes. BHV Partners is also providing advisory support to the startup.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2020